HomeInsightsPE

Godavari Drugs Ltd PE Ratio

Godavari Drugs Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 3, 2024)

stocks purchased

5.2 K

Stocks Traded

(Dec 3, 2024)

Last Updated on: Dec 03, 2024

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

PE

13.8

Last updated on: Dec 03, 2024

Key Highlights

  • The P/E Ratio of Godavari Drugs Ltd is 13.8 as of 03 Dec 13:51 PM .
  • The P/E Ratio of Godavari Drugs Ltd changed from 14.6 on March 2019 to 12.6 on March 2024 . This represents a CAGR of -2.43% over 6 years.
  • The Latest Trading Price of Godavari Drugs Ltd is ₹ 122.15 as of 03 Dec 13:42 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Godavari Drugs Ltd

No data available

Company Fundamentals for Godavari Drugs Ltd

No data available

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

Share Price

₹ 122.15

0.35 (0.29%)

stock direction

Last updated on: Dec 03, 2024

Market Price of Godavari Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Godavari Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Dec 2024121.8
29 Nov 2024123.5
28 Nov 2024114.5
27 Nov 2024113.6
26 Nov 2024114.55
25 Nov 2024117.4
22 Nov 2024114.5
21 Nov 2024113.5
19 Nov 2024115.5
18 Nov 2024115.45

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Godavari Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Godavari Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Godavari Drugs Ltd1391
Sun Pharmaceuticals Industries Ltd384,33,848
Divis Laboratories Ltd901,65,923
Cipla Ltd261,21,796
Torrent Pharmaceuticals Ltd641,12,982
Mankind Pharma Ltd491,04,785

Key Valuation Metric of Godavari Drugs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Godavari Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Godavari Drugs Ltd

No data available

* All values are in %

About Godavari Drugs Ltd

  • Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
  • Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

Godavari Drugs Ltd News Hub

News

Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter

Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 ...

Read more

2024-08-14 00:00:00

News

Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

2024-08-10 00:00:00

News

Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter

Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2...

Read more

2024-11-14 00:00:00

News

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November...

Read more

2024-11-09 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Godavari Drugs Ltd

What is the current PE Ratio of Godavari Drugs Ltd?

The Current PE Ratio of Godavari Drugs Ltd is 13.75 as on 3 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 3 Dec 2024.

What was the PE Ratio of Godavari Drugs Ltd last year?

The PE Ratio of Godavari Drugs Ltd was 15.06 last year, now the PE ratio is 13.75, showing a year-on-year growth of -8.7%.

What does the PE Ratio of Godavari Drugs Ltd indicate about its stock?

The PE Ratio of Godavari Drugs Ltd is 13.75. This ratio indicates that investors are willing to pay 13.75 times the earnings per share for each share of Godavari Drugs Ltd.

What is the PE Ratio Growth of Godavari Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Godavari Drugs Ltd grew by -8.7% whereas, the EPS ratio grew by -33.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading starting at just

Rs. 249*